Lecanemab in Early Alzheimer's Disease.

RPEP-074882023van Dyck, Christopher H; Swanson, Chad J; Aisen, Paul; Bateman, Randall J; Chen, Christopher; Gee, Michelle; Kanekiyo, Michio; Li, David; Reyderman, Larisa; Cohen, Sharon; Froelich, Lutz; Katayama, Sadao; Sabbagh, Marwan; Vellas, Bruno; Watson, David; Dhadda, Shobha; Irizarry, Michael; Kramer, Lynn D; Iwatsubo, Takeshi

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Lecanemab in Early Alzheimer's Disease.

The New England journal of medicine, 388(1), 9-21

View on PubMed ↗Publisher’s paper ↗

Citation

van Dyck, Christopher H; Swanson, Chad J; Aisen, Paul; Bateman, Randall J; Chen, Christopher; Gee, Michelle; Kanekiyo, Michio; Li, David; Reyderman, Larisa; Cohen, Sharon; Froelich, Lutz; Katayama, Sadao; Sabbagh, Marwan; Vellas, Bruno; Watson, David; Dhadda, Shobha; Irizarry, Michael; Kramer, Lynn D; Iwatsubo, Takeshi. (2023). Lecanemab in Early Alzheimer's Disease.. The New England journal of medicine, 388(1), 9-21. https://doi.org/10.1056/NEJMoa2212948